Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-6 of  6 results for ""Fallah J""

Your Filters

Geographic : united states Filter by : Author
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Efficacy of Poly(ADP-ribose) Polymerase Inhibitors by Individual Genes in Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer: A US Food and Drug Administration Pooled Analysis.

  • Authors : Fallah J; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, MD.; Xu J

Subjects: Prostatic Neoplasms, Castration-Resistant*/Prostatic Neoplasms, Castration-Resistant*/Prostatic Neoplasms, Castration-Resistant*/drug therapy ; Prostatic Neoplasms, Castration-Resistant*/Prostatic Neoplasms, Castration-Resistant*/Prostatic Neoplasms, Castration-Resistant*/genetics ; Prostatic Neoplasms, Castration-Resistant*/Prostatic Neoplasms, Castration-Resistant*/Prostatic Neoplasms, Castration-Resistant*/pathology

  • Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 May 10; Vol. 42 (14), pp. 1687-1698. Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

FDA Approval Summary: Olaparib in Combination With Abiraterone for Treatment of Patients With BRCA -Mutated Metastatic Castration-Resistant Prostate Cancer.

  • Authors : Fallah J; Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD.; Xu J

Subjects: Prostatic Neoplasms, Castration-Resistant*/Prostatic Neoplasms, Castration-Resistant*/Prostatic Neoplasms, Castration-Resistant*/drug therapy ; Prostatic Neoplasms, Castration-Resistant*/Prostatic Neoplasms, Castration-Resistant*/Prostatic Neoplasms, Castration-Resistant*/genetics ; Androstenes*

  • Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Feb 10; Vol. 42 (5), pp. 605-613. Date Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

A U.S. Food and Drug Administration-pooled Analysis of Frontline Combination Treatment Survival Benefits by Risk Groups in Metastatic Renal Cell Carcinoma.

  • Authors : Lee D; Center for Drug Evaluation and Research, Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, MD, USA. Electronic address: .; Gittleman H

Subjects: Carcinoma, Renal Cell*/Carcinoma, Renal Cell*/Carcinoma, Renal Cell*/pathology ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/adverse effects ; Kidney Neoplasms*/Kidney Neoplasms*/Kidney Neoplasms*/pathology

  • Source: European urology [Eur Urol] 2023 Oct; Vol. 84 (4), pp. 373-378. Date of Electronic Publication: 2023 Jun 02.Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Prostate Cancer Theranostics: Concurrent Approvals by the Food and Drug Administration of the First Diagnostic Imaging Drug Indicated to Select Patients for a Paired Radioligand Therapeutic Drug.

  • Authors : Hofling AA; Division of Imaging and Radiation Medicine, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland; .

Subjects: Precision Medicine* ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/therapy; United States

  • Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2022 Nov; Vol. 63 (11), pp. 1642-1643. Date of Electronic Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print-Electronic

Record details

Read More Add to Saved list
×
Academic Journal

Survival outcomes in older men with non-metastatic castration-resistant prostate cancer treated with androgen receptor inhibitors: a US Food and Drug Administration pooled analysis of patient-level data from three randomised trials.

  • Authors : Fallah J; Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Food and Drug Administration, Silver Spring, MD, USA. Electronic address: .; Zhang L

Subjects: Androgen Receptor Antagonists/Androgen Receptor Antagonists/Androgen Receptor Antagonists/*therapeutic use ; Prostatic Neoplasms, Castration-Resistant/Prostatic Neoplasms, Castration-Resistant/Prostatic Neoplasms, Castration-Resistant/*drug therapy; Aged

  • Source: The Lancet. Oncology [Lancet Oncol] 2021 Sep; Vol. 22 (9), pp. 1230-1239. Date of Electronic Publication: 2021 Jul 23.Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Diagnostic and therapeutic splenectomy for splenic lymphomas: analysis of the National Cancer Data Base.

  • Authors : Fallah J; a Cleveland Clinic Taussig Cancer Institute , Cleveland , OH , USA.; Olszewski AJ

Subjects: Databases, Factual* ; Lymphoma, B-Cell, Marginal Zone*/Lymphoma, B-Cell, Marginal Zone*/Lymphoma, B-Cell, Marginal Zone*/diagnosis ; Lymphoma, B-Cell, Marginal Zone*/Lymphoma, B-Cell, Marginal Zone*/Lymphoma, B-Cell, Marginal Zone*/mortality

  • Source: Hematology (Amsterdam, Netherlands) [Hematology] 2019 Dec; Vol. 24 (1), pp. 378-386.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9708388 Publication Model: Print Cited Medium: Internet ISSN: 1607-8454

Record details

Read Online Read More Add to Saved list
×
  • 1-6 of  6 results for ""Fallah J""